REG - Goodbody Health Inc. - Update on Completion of Continuation

Green Cross HealthAnnouncement

23/08/2022 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220823:nRSW9672Wa&default-theme=true

RNS Number : 9672W  Goodbody Health Inc.  23 August 2022

23rd August 2022

Goodbody Health Inc.

(Renamed: Goodbody Health Limited)

("Goodbody Health", or the "Company")

Goodbody Health Provides Shareholders Update on Completion of Continuation

Goodbody Health (AQSE: GDBY) is pleased to confirm the completion of the
Company's continuation to Guernsey, effective August 19th, 2022, as previously
announced which changes the name from Goodbody Health Inc. to Goodbody Health
Limited.  Also as previously announced, the Company's voluntary delisting
from the CSE occurred at the close of trading on August 17, 2022 after the
suspension of trading on the AQSE on August 16, 2022. Shortly thereafter the
ten for one share consolidation of the Company's issued and outstanding shares
became effective on August 18, 2022. Following the consolidation, and upon the
re-commencement of trading on the AQSE, the Company will have 36,496,276
Ordinary Shares issued and outstanding.

 

Trading is anticipated to resume on the AQSE on Wednesday, the 24(th) August
2022 following the continuation.

 

The Company has published Frequently Asked Questions (FAQs) in regards to the
information and the continuation procedures relevant to shareholders on its
website to be found at
https://goodbodyhealth.com/agm-proposed-re-domiciliation/
(https://goodbodyhealth.com/agm-proposed-re-domiciliation/)

 

Geremy Thomas, Executive Chairman, said: "This move is part of a
simplification of the business, allowing the company management to focus on
the London market and the growth of the diagnostic testing business. We look
forward to exciting times ahead."

 

The Directors of the Company accept responsibility for the contents of this
announcement.

 

For further information:

 Marc Howells                                               Anne Tew

 Chief Executive Officer                                    Chief Financial Officer

 Goodbody Health Inc.                                       Goodbody Health Inc.

 +44 (0) 20 7971 1255                                       +44 (0) 20 7971 1255

 enquiries@goodbodyhealth.com                               enquiries@goodbodyhealth.com

  www.goodbodyhealth.com (http://www.goodbodyhealth.com)     www.goodbodyhealth.com (http://www.goodbodyhealth.com)

                                                            AQSE Corporate Adviser

                                                            Peterhouse Capital Limited

                                                            Guy Miller/Mark Anwyl

                                                            +44 (0) 20 7469 0930

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXMZGZRDFNGZZM